19/06/2013 12:17:27 Free Membership Login
Adeza Biomedical (MM)
   

   

Adeza

Visual Financials
Adeza stock quote | Adeza company information | Adeza Stock Chart | Adeza Stock News
Company Name: Adeza Biomedical Corporation
Ticker Symbol: ADZA
WWW Address: www.adeza.com
CEO: Emory V. Anderson
No. of Employees: 125
Common Issue Type: CS
Business Description:Designs, develops, manufactures and markets innovative products for women's health. The Company's initial focus is on reproductive healthcare, using its proprietary technologies to predict preterm birth and assess infertility.

 
Industry Information: DRUGS - Diagnostic Support [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
  Unchanged     24.36 23.88 
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 0.0 17.6 -1.04 0.14 0.00 172.3 0.0 24.78 - 12.61
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close24.12$
PE Ratio - LTM172.3
Market Capitalisation0.0mil
Latest Shares Outstanding17.6mil
Earnings pS (EPS)0.14$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee415,864$
Effective Tax Rate0.0%
Float17.5mil
Float as % of Shares Outstanding99.8%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue68.90%
Research & Devlopment (R&D) as % of Revenue13.30%
Gross Profit Margin85.2%
EBITDA Margin3.0%
Pre-Tax Profit Margin11.6%
Assets Turnover0.5%
Return on Assets (ROA)2.2%
Return on Equity (ROE)2.4%
Return on Capital Invested (ROCI)2.4%
Current Ratio13.0
Leverage Ratio (Assets/Equity)1.1
Interest Cover0.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Total Capital0.0%
Working Capital pS6.06$
Cash pS2.62$
Book-Value pS6.10$
Tangible Book-Value pS6.10$
Cash Flow pS0.16$
Free Cash Flow pS0.32$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.95
Price/Tangible Book Ratio3.95
Price/Cash Flow150.8
Price/Free Cash Flow75.4
P/E as % of Industry Group638.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---1.01005651,503
4 Weeks24.3623.8524.000.5981,10118,718
13 Weeks24.7813.8014.5765.51623,355201,284
26 Weeks24.7813.0516.0350.51412,241271,147
52 Weeks24.7812.6120.0120.51091,875463,244
YTD24.7813.80-61.81603,224203,120
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
24.0524.0221.3617.5016.92-1.04-1.11
 
GROWTH RATES5-Year
Growh		R² of 5-Year Growth3-Year
Growth
Revenue48.3291.925.63
Income0.000.0-16.46
Dividend0.000.00.00
Capital Spending0.00NA32.83
R&D28.49NA55.99
Normalized Inc.0.00NA-81.61
 
CHANGESYTD vs.
Last YTD		Curr Qtr vs.
Qtr 1-Yr ago		Annual vs.
Last Annual
Revenue %19.223.019.2
Earnings %-79.5-82.1-79.5
EPS %-79.7-81.6-79.7
EPS $-0.55-0.31-0.55
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio91.74
Current Ratio13.0
Quick Ratio (Acid Test)12.2
Liquidity Ratio (Cash)11.16
Receivables Turnover5.5
Average Collection Period65
Working Capital/Equity99.3
Working Capital pS6.06
Cash-Flow pS0.16
Free Cash-Flow pS0.32
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio30.42
Financial Leverage Ratio (Assets/Equity)1.1
Debt Ratio7.6
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities0.0
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.79
Tobin's Q Ratio3.65
Current P/E Ratio - LTM172.30
Enterprise Value (EV)/EBITDA214.35
Enterprise Value (EV)/Free Cash Flow67.59
Dividend Yield0.0
Price/Tangible Book Ratio - LTM3.95
Price/Book Ratio - LTM3.95
Price/Cash Flow Ratio150.8
Price/Free Cash Flow Ratio - LTM75.4
Price/Sales Ratio8.15
P/E Ratio (1 month ago) - LTM171.7
P/E Ratio (26 weeks ago) - LTM30.2
P/E Ratio (52 weeks ago) - LTM29.0
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group638.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM172.3
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS0.50
Tangible Book Value pS - LTM6.10
Book Value pS - LTM6.10
Capital Invested pS6.10
Cash pS - LTM2.62
Cash Flow pS - LTM0.16
Free Cash Flow pS - LTM0.32
Earnings pS (EPS)0.14
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin10.72
Free Cash Flow Margin 5YEAR AVG7.67
Net Profit Margin4.9
Net Profit Margin - 5YEAR AVRG.15.7
Equity Productivity0.49
Return on Equity (ROE)2.4
Return on Equity (ROE) - 5YEAR AVRG.14.8
Capital Invested Productivity0.49
Return on Capital Invested (ROCI)2.4
Return on Capital Invested (ROCI) - 5YEAR AVRG.14.8
Assets Productivity0.50
Return on Assets (ROA)2.2
Return on Assets (ROA) - 5YEAR AVRG.7.7
Gross Profit Margin85.2
Gross Profit Margin - 5YEAR AVRG.85.2
EBITDA Margin - LTM3.0
EBIT Margin - LTM11.6
Pre-Tax Profit Margin11.6
Pre-Tax Profit Margin - 5YEAR AVRG.15.4
Effective Tax Rate58.1
Effective Tax Rate - 5YEAR AVRG.1.8
EFFICIENCY RATIOS
Cash Conversion Cycle109
Revenue per Employee415,864
Net Income per Employee20,216
Average Collection Period66
Receivables Turnover5.5
Day's Inventory Turnover Ratio43
Inventory Turnover8.4
Inventory/Sales1.9
Accounts Payble/Sales4.56
Assets/Revenue2.00
Net Working Capital Turnover0.49
Fixed Assets Turnover71.90
Total Assets Turnover0.5
Revenue per $ Cash1.13
Revenue per $ Plant114.50
Revenue per $ Common Equity0.49
Revenue per $ Capital Invested0.49
Selling, General & Adm/tive (SG&A) as % of Revenue68.9
SG&A Expense as % of Revenue - 5YEAR AVRG.63.5
Research & Devlopment (R&D) as % of Revenue13.3
R&D Expense as % of Revenue - 5YEAR AVRG.13.3

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's

1 site:2 us nasdaq adza130619 12:17